News
News from us and our partners
News
News
Industrial Biotech
News
Capital
News
Digital Medicine
News
Tags
Topics
0 results
- News
GenSight Biologics announces a successful offering for an amount over €9.2 million
- News
Mediar advances first-in-class fibrosis portfolio to the clinic with first cohort dosing in Phase 1 trial of MTX-463 and establishes clinical advisory board
- News
Calliditas announces positive topline results of Phase 2 head and neck cancer trial with lead NOX inhibitor candidate, setanaxib
- News
Amolyt Pharma Granted FDA Fast Track Designation for Eneboparatide for the Treatment of Hypoparathyroidism
- News
Sofinnova’s newest partners discuss their career paths
- News
Sofinnova Partners appoints two new partners, strengthening team of next generation investors
- News
Sitryx nominates SYX-5219 a novel, oral and targeted PKM2 activator for clinical development in atopic dermatitis
- News
Sensorion announces a €15 Million financing, extending cash runway until the end of 2025
- News
Johnson & Johnson to acquire Shockwave Medical
- News
Moon Surgical expands to gynecological surgery
- News
Asceneuron joins critical path for Alzheimer’s Disease Consortium
- News
Cure51 raises a €15 million seed round to harness the natural power of cancer survivors to develop first in class treatments and transform cancer into a curable disease
- News
Moon Surgical's Maestro System powered by NVIDIA Holoscan paves the way to next-generation laparoscopy, with over 200 patients treated
- News
Biotalys and Novonesis announce manufacturing and commercialisation partnership for EVOCA NG
- News
Sofinnova Partners portfolio company Amolyt Pharma to be acquired by AstraZeneca